Search by Drug Name or NDC
NDC 51660-0753-31 Loratadine 5 mg/1 Details
Loratadine 5 mg/1
Loratadine is a ORAL TABLET, CHEWABLE in the HUMAN OTC DRUG category. It is labeled and distributed by Ohm Laboratories Inc.. The primary component is LORATADINE.
MedlinePlus Drug Summary
Loratadine is used to temporarily relieve the symptoms of hay fever (allergy to pollen, dust, or other substances in the air) and other allergies. These symptoms include sneezing, runny nose, and itchy eyes, nose, or throat. Loratadine is also used to treat itching and redness caused by hives. However, loratadine does not prevent hives or other allergic skin reactions. Loratadine is in a class of medications called antihistamines. It works by blocking the action of histamine, a substance in the body that causes allergic symptoms. Loratadine is also available in combination with pseudoephedrine (Sudafed, others). This monograph only includes information about the use of loratadine alone. If you are taking the loratadine and pseudoephedrine combination product, read the information on the package label or ask your doctor or pharmacist for more information.
Related Packages: 51660-0753-31Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Loratadine
Product Information
NDC | 51660-0753 |
---|---|
Product ID | 51660-753_48a60b3d-d011-4d0f-84dc-414c713c76ba |
Associated GPIs | |
GCN Sequence Number | 062340 |
GCN Sequence Number Description | loratadine TAB CHEW 5 MG ORAL |
HIC3 | Z2Q |
HIC3 Description | ANTIHISTAMINES - 2ND GENERATION |
GCN | 98118 |
HICL Sequence Number | 007605 |
HICL Sequence Number Description | LORATADINE |
Brand/Generic | Generic |
Proprietary Name | Loratadine |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Loratadine |
Product Type | HUMAN OTC DRUG |
Dosage Form | TABLET, CHEWABLE |
Route | ORAL |
Active Ingredient Strength | 5 |
Active Ingredient Units | mg/1 |
Substance Name | LORATADINE |
Labeler Name | Ohm Laboratories Inc. |
Pharmaceutical Class | n/a |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA210088 |
Listing Certified Through | 2024-12-31 |
Package
Package Images

NDC 51660-0753-31 (51660075331)
NDC Package Code | 51660-753-31 |
---|---|
Billing NDC | 51660075331 |
Package | 3 BLISTER PACK in 1 CARTON (51660-753-31) / 10 TABLET, CHEWABLE in 1 BLISTER PACK |
Marketing Start Date | 2018-06-01 |
NDC Exclude Flag | N |
Pricing Information | |
Price Per Unit | 0.404 |
Pricing Unit | EA |
Effective Date | 2022-05-18 |
NDC Description | CHILD LORATADINE 5 MG TAB CHEW |
Pharmacy Type Indicator | C/I |
OTC | Y |
Explanation Code | 4 |
Classification for Rate Setting | G |
As of Date | 2022-11-23 |
Standard Product Labeling (SPL)/Prescribing Information SPL b83de07d-37f4-42b4-b43e-29173454bef0 Details
Uses
Warnings
Do not use if you have ever had an allergic reaction to this product or any of its ingredients.
Ask a doctorbefore use if you have liver or kidney disease. Your doctor should determine if you need a different dose.
When using this product do not take more than directed. Taking more than directed may cause drowsiness.
Stop use and ask a doctor if an allergic reaction to this product occurs. Seek medical help right away.
If pregnant or breast-feeding, ask a health professional before.
Directions
- •
- chew or crush tablets completely before swallowing.
adults and children 6 years and over |
chew 2 tablets daily; not more than 2 tablets in 24 hours |
children 2 to under 6 years of age |
chew 1 tablet daily; not more than 1 tablet in 24 hours |
children under 2 years of age |
ask a doctor |
consumers with liver or kidney disease |
ask a doctor |
Other information
Inactive ingredients
Questions?
Principal Display Panel – 30 Chewable Tablet Blister Pack Carton
NDC 51660-753-31
†Compare to the active ingredient of Children’s Claritin® Chewable
ages 2 years and older
Children’s
Loratadine Chewable Tablets USP, 5 mg
Antihistamine
Indoor & Outdoor Allergies
30 CHEWABLE TABLETS
The chewable tablets are to be chewed before swallowing.
Grape Flavored
Non-Drowsy*
24 Hour Relief Of:
- •
- Sneezing
- •
- Runny Nose
- •
- Itchy, Watery Eyes
- •
- Itchy Nose or Throat
*When taken as directed. See Drug Facts Panel.
†Ohm® is a registered trademark of Sun Pharmaceutical Industries, Inc. All other trademarks are property of their respective owners.
INGREDIENTS AND APPEARANCE
LORATADINE
loratadine tablet, chewable |
||||||||||||||||||||||||
|
||||||||||||||||||||||||
|
||||||||||||||||||||||||
|
||||||||||||||||||||||||
|
||||||||||||||||||||||||
|
||||||||||||||||||||||||
|
Labeler - Ohm Laboratories Inc. (184769029) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
---|---|---|---|
Ohm Laboratories Inc. | 184769029 | MANUFACTURE(51660-753) |